Martine Dubois
Rouen, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
The urotensin II receptor triggers an early meningeal response and a delayed macrophage-dependent vasospasm after subarachnoid hemorrhage in male mice.
Journal: Nature communications
Published: January 17, 2023
Cognitive assessment in patients treated by immunotherapy: the prospective Cog-Immuno trial.
Journal: BMC cancer
Published: October 20, 2022
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 17, 2019
Urantide Improves Cardiac Function, Modulates Systemic Cytokine Response, and Increases Survival in A Murine Model of Endotoxic Shock.
Journal: Shock (Augusta, Ga.)
Published: October 01, 2019
How to assess and manage cognitive impairment induced by treatments of non-central nervous system cancer.
Journal: Neuroscience and biobehavioral reviews
Published: June 12, 2019
Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
Journal: BMC cancer
Published: November 09, 2017
Association between vasoactive peptide urotensin II in plasma and cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a potential therapeutic target.
Journal: Journal of neurosurgery
Published: September 15, 2017
Long-Lasting Cerebral Vasospasm, Microthrombosis, Apoptosis and Paravascular Alterations Associated with Neurological Deficits in a Mouse Model of Subarachnoid Hemorrhage.
Journal: Molecular neurobiology
Published: February 11, 2017
Biomarkers Associated with Cognitive Impairment in Treated Cancer Patients: Potential Predisposition and Risk Factors.
Journal: Frontiers in pharmacology
Published: November 15, 2016
Last Updated: 09/26/2026